162 related articles for article (PubMed ID: 24597666)
1. Decoy receptor 3 (DcR3) overexpression predicts the prognosis and pN2 in pancreatic head carcinoma.
Zhou J; Song S; Li D; He S; Zhang B; Wang Z; Zhu X
World J Surg Oncol; 2014 Mar; 12():52. PubMed ID: 24597666
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of expression and amplification of the DcR3 gene in pancreatic carcinomas.
Zhou J; Song SD; Li DC; Zhou J; Zhu DM; Zheng SY
Asian Pac J Cancer Prev; 2012; 13(2):719-24. PubMed ID: 22524850
[TBL] [Abstract][Full Text] [Related]
3. DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors.
Edfeldt K; Daskalakis K; Bäcklin C; Norlén O; Tiensuu Janson E; Westin G; Hellman P; Stålberg P
Neuroendocrinology; 2017; 105(2):170-181. PubMed ID: 27829249
[TBL] [Abstract][Full Text] [Related]
4. Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients.
Yang M; Chen G; Dang Y; Luo D
Ups J Med Sci; 2010 Nov; 115(4):232-7. PubMed ID: 20977315
[TBL] [Abstract][Full Text] [Related]
5. High DcR3 expression predicts stage pN2-3 in gastric cancer.
Wu Y; Guo E; Yu J; Xie Q
Am J Clin Oncol; 2008 Feb; 31(1):79-83. PubMed ID: 18376232
[TBL] [Abstract][Full Text] [Related]
6. High DcR3 expression predicts stage pN2 in gastric cancer.
Wu Y; Guo E; Yu J; Xie Q; Chen J
Hepatogastroenterology; 2007; 54(79):2172-6. PubMed ID: 18251184
[TBL] [Abstract][Full Text] [Related]
7. Overexpression and clinicopathological contribution of DcR3 in bladder urothelial carcinoma tissues.
Jiang YQ; Zhong TF; Dang YW; Zou LS; Yang L; Yang X; Chen G
Asian Pac J Cancer Prev; 2014; 15(21):9137-42. PubMed ID: 25422191
[TBL] [Abstract][Full Text] [Related]
8. Death decoy receptor overexpression and increased malignancy risk in colorectal cancer.
Zong L; Chen P; Wang DX
World J Gastroenterol; 2014 Apr; 20(15):4440-5. PubMed ID: 24764685
[TBL] [Abstract][Full Text] [Related]
9. [Association of serum decoy receptor 3 protein level with the clinicopathologic features of bladder transitional cell carcinoma].
Wang D; Wang J; Chen G
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Dec; 33(12):1831-2. PubMed ID: 24369256
[TBL] [Abstract][Full Text] [Related]
10. Decoy receptor 3 is a prognostic factor in renal cell cancer.
Macher-Goeppinger S; Aulmann S; Wagener N; Funke B; Tagscherer KE; Haferkamp A; Hohenfellner M; Kim S; Autschbach F; Schirmacher P; Roth W
Neoplasia; 2008 Oct; 10(10):1049-56. PubMed ID: 18813347
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.
Takahama Y; Yamada Y; Emoto K; Fujimoto H; Takayama T; Ueno M; Uchida H; Hirao S; Mizuno T; Nakajima Y
Gastric Cancer; 2002; 5(2):61-8. PubMed ID: 12111580
[TBL] [Abstract][Full Text] [Related]
13. Serum decoy receptor 3 is a biomarker for disease severity in nonatopic asthma patients.
Chen MH; Kan HT; Liu CY; Yu WK; Lee SS; Wang JH; Hsieh SL
J Formos Med Assoc; 2017 Jan; 116(1):49-56. PubMed ID: 26911723
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma.
Chen G; Luo D
Ups J Med Sci; 2008; 113(3):297-304. PubMed ID: 18991242
[TBL] [Abstract][Full Text] [Related]
15. Expression and Clinical Significance of Decoy Receptor 3 in Acute-on-Chronic Liver Failure.
Lin S; Wu B; Lin Y; Wang M; Zhu Y; Jiang J; Zhang L; Lin J
Biomed Res Int; 2019; 2019():9145736. PubMed ID: 31317042
[TBL] [Abstract][Full Text] [Related]
16. Serum decoy receptor 3 (DcR3): a promising biomarker for atopic asthma in children.
Kamal A; Abdelmegeid AK; Gabr MAM; Basanti CWS
Immunol Res; 2021 Dec; 69(6):568-575. PubMed ID: 34383195
[TBL] [Abstract][Full Text] [Related]
17. DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters.
Liang QL; Wang BR; Li GH
J Zhejiang Univ Sci B; 2009 Sep; 10(9):675-82. PubMed ID: 19735100
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesis.
Wu Q; Zheng Y; Chen D; Li X; Lu C; Zhang Z
J Surg Res; 2014 May; 188(2):459-65. PubMed ID: 24612949
[TBL] [Abstract][Full Text] [Related]
19. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
20. Decoy Receptor 3 (DcR3) as a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis.
Jiang M; Lin X; He R; Lin X; Liang L; Tang R; Xiong D; Wei K; Dang Y; Feng Z; Chen G
Med Sci Monit; 2016 Jun; 22():1850-7. PubMed ID: 27246752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]